Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Mallinckrodt
Fuji
Queensland Health
Johnson and Johnson
Deloitte
Accenture
McKesson
UBS

Generated: May 21, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: SAQUINAVIR MESYLATE

« Back to Dashboard

SAQUINAVIR MESYLATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Hoffmann La Roche INVIRASE saquinavir mesylate CAPSULE;ORAL 020628 NDA Genentech, Inc. N 0004-0245-15
Hoffmann-la Roche INVIRASE saquinavir mesylate TABLET;ORAL 021785 NDA Genentech, Inc. N 0004-0244-51
Hoffmann-la Roche INVIRASE saquinavir mesylate TABLET;ORAL 021785 NDA State of Florida DOH Central Pharmacy N 53808-0674-1
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Deloitte
US Department of Justice
Julphar
UBS
Covington
QuintilesIMS
Chinese Patent Office
AstraZeneca